27 Acute liver failure (ALF) or fulminant hepatitis is a rare, yet severe outcome of 28 infection with hepatitis B virus (HBV) that carries a high mortality rate. The occurrence 29 of a life-threatening condition upon infection with a prevalent virus in individuals 30 without known risk factors is suggestive of pathogen-specific immune dysregulation. 31 In the absence of established differences in HBV virulence, we hypothesized that ALF 32 upon primary infection with HBV could be due to rare deleterious variants in the human 33 genome. To search for such variants, we performed exome sequencing in 21 previously 34 healthy adults who required liver transplantation upon fulminant HBV infection and 35 172 controls that were positive for anti-HBc and anti-HBs antibodies but had no clinical 36 history of jaundice or liver disease. After a series of hypothesis-driven filtering steps, 37 we searched for putatively pathogenic variants that were significantly associated with 38 case-control status. We did not find any causal variant or gene, a result that does not 39 support the hypothesis of a shared monogenic basis for human susceptibility to HBV-40 related ALF in adults. This study represents a first attempt at deciphering the human 41 genetic contribution to the most severe clinical presentation of acute HBV infection in 42 previously healthy individuals.
76 Electing patients with extreme phenotype increases the power to detect causal gene as 77 variants as these patients are more likely to carry alleles with profound functional 78 consequences that are otherwise very rare in the population, due to purifying selection 79 [16] [17] [18] [19] [20] . In this study, we used exome sequencing and statistical analysis in a cohort of 80 21 cases and 172 controls to search for human genetic variants conferring extreme 81 susceptibility to HBV. Cases were previously healthy adults who required liver 82 transplantation for fulminant hepatitis B and controls were HBV-infected adults who 83 did not develop fulminant hepatitis (Figure 1 245
The following demographic and clinical information were collected: age at 246 transplantation date, gender, and ethnicity. For each study participant, we obtained 3ml 247 of blood in EDTA vacutainer tubes and 2,5ml blood in PAXgene blood RNA tubes.
248 Samples were immediately frozen at -70°C, and then shipped and analyzed in batch. 
